Insider Trading Summary for Amicus Therapeutics, Inc. (FOLD): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Mar-24 5:36 PM View:	07-Mar-24 Option Exercise $42.00K	Sblendorio Glenn Director		Amicus Therapeutics, Inc. - FOLD	17% 71.72K to 83.6K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 10:00 PM View:	05-Mar-24 Option Exercise $42.00K	Raab Michael Director		Amicus Therapeutics, Inc. - FOLD	39% 60.01K to 83.6K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 10:00 PM View:	05-Mar-24 Option Sale ($100.50K)	McGlynn Margaret G Director		Amicus Therapeutics, Inc. - FOLD	17% 50.7K to 59.29K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 5:35 PM View:	08-Jun-23 Grant 0	Wheeler Craig A Director		Amicus Therapeutics, Inc. - FOLD	20% 43.79K to 52.37K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 5:39 PM View:	08-Jun-23 Grant 0	Bleil Lynn Dorsey Director		Amicus Therapeutics, Inc. - FOLD	12% 73.1K to 81.68K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 5:20 PM View:	15-Feb-24 Private Sale ($61.98K)	Clark David Michael Chief People Officer		Amicus Therapeutics, Inc. - FOLD	5% 241.07K to 253.66K	0	0	--	--	Show Txns Hide Txns

08-Feb-24 4:40 PM View:	07-Feb-24 Option Sale ($384.82K)	Rosenberg Ellen Chief Legal Officer		Amicus Therapeutics, Inc. - FOLD	10% 347.35K to 382.65K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 5:36 PM View:	08-Jun-23 Grant 0	Whitman Burke W Director		Amicus Therapeutics, Inc. - FOLD	11% 77.75K to 86.34K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 5:40 PM View:	08-Jun-23 Grant 0	Kelly Michael Aaron Director		Amicus Therapeutics, Inc. - FOLD	27% 31.62K to 40.21K	0	0	--	--	Show Txns Hide Txns

12-Jun-23 5:38 PM View:	08-Jun-23 Grant 0	Roberts Eiry Director		Amicus Therapeutics, Inc. - FOLD	24% 35.43K to 44.01K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 5:14 PM View:	01-Mar-24 Private Sale ($389.54K)	Crowley John F Executive Chairman Director		Amicus Therapeutics, Inc. - FOLD	(39%) 1.04M to 638.37K	0	($466.43K) (4%)	--	$10.50 - $11.36	Show Txns Hide Txns

11-Jan-24 6:34 PM View:	09-Jan-24 Payment of Exercise ($136.57K)	Castelli Jeff Chief Development Officer		Amicus Therapeutics, Inc. - FOLD	(5%) 383.15K to 362.8K	0	0	--	--	Show Txns Hide Txns

16-Apr-24 5:42 PM View:	15-Apr-24 Payment of Exercise ($74.91K)	Prout Samantha Whiteman Chief Accounting Officer		Amicus Therapeutics, Inc. - FOLD	(46%) 137.0K to 73.93K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 6:17 PM View:	02-Jan-24 Grant 0	Harford Simon N.R. Chief Financial Officer		Amicus Therapeutics, Inc. - FOLD	100% 0 to 164.37K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 6:14 PM View:	01-Apr-24 Market Option Sale ($87.50K)	Campbell Bradley L President and CEO Director		Amicus Therapeutics, Inc. - FOLD	8% 823.45K to 886.65K	0	($87.50K) (1%)	--	$11.67	Show Txns Hide Txns

Buy:	0	--
Sell:	($553.93K)	$10.50 - $11.67

Amicus Therapeutics, Inc. (FOLD)

Last Year

24-Apr-23 -- 23-Apr-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

24-Apr-22 -- 23-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades